← EU Feed

Tris Pharma Appoints Jim Potenziano, Ph.D. as Chief Science and Development Officer

AI Briefing

  • Tris Pharma appoints Jim Potenziano, Ph.D. as Chief Science and Development Officer
  • New role reflects company's commitment to integrated innovation across CNS disorders
  • Jim Potenziano, Ph.D. to lead Tris Pharma's scientific efforts
Advertisement
Read Original Article